Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive congenital malformation syndrome caused by mutations in the 7-dehydrocholesterol reductase gene. This inborn error of cholesterol synthesis leads to elevated concentrations of 7-dehydrocholesterol (7-DHC). 7-DHC also serves as the precursor for vitamin D 
Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive congenital malformation syndrome caused by mutations in the 7-dehydrocholesterol reductase gene. This inborn error of cholesterol synthesis leads to elevated concentrations of 7-dehydrocholesterol (7-DHC). 7-DHC also serves as the precursor for vitamin D synthesis. Limited data is available on vitamin D levels in individuals with SLOS. Due to elevated concentrations of 7-DHC, we hypothesized that vitamin D status would be abnormal and possibly reach toxic levels in patients with SLOS. Through a retrospective analysis of medical records between 1998 and 2006, we assessed markers of vitamin D and calcium metabolism from 53 pediatric SLOS patients and 867 pediatric patients who were admitted to the NIH Clinical Center (NIHCC) during the same time period. SLOS patients had significantly higher levels of 25(OH)D (48.06 ± 19.53 ng/ml, p < 0.01) across all seasons in comparison to the NIHCC pediatric patients (30.51 ± 16.14 ng/ml). Controlling for season and age of blood draw, 25(OH)D levels were, on average, 15.96 ng/ml (95%CI 13.95-17.90) higher in SLOS patients.
Although, mean calcium values for both patient cohorts never exceeded the normal clinical reference range (8.6-10.2 mg/dl), the levels were higher in the SLOS cohort (9.49 ± 0.56 mg/dl, p < 0.01) compared to the NIHCC patients (9.25 ± 0.68 mg/dl).
Overall, in comparison to the control cohort, individuals with SLOS have significantly higher concentrations of 25(OH)D that may be explained by elevated concentrations of serum 7-DHC. Despite the elevated vitamin D levels, there was no laboratory or clinical evidence of vitamin D toxicity.
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| INTRODUCTION
Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive malformation syndrome caused by mutations in the gene encoding the enzyme 7-dehydrocholesterol reductase (DHCR7) (Fitzky et al., 1998; Wassif et al., 1998; Waterham et al., 1998) . This enzyme is responsible for the reduction of 7-dehydrocholesterol (7-DHC) to cholesterol in the last step of the Kandutsch-Russel pathway of cholesterol biosynthesis. Individuals with SLOS present with abnormally elevated concentrations of 7-DHC, low to normal cholesterol levels and variable malformations (Irons, Elias, Salen, Tint, & Batta, 1993) . In addition to its role as a diagnostic metabolite for SLOS (Kelley & Hennekam, 2000; Porter, 2008) , 7-DHC is physiologically important as the precursor for the cutaneous synthesis of the prohormone, vitamin D (Holick et al., 1980) . Vitamin D status is considered extremely important for calcium homeostasis and health promotion (Holick, 1996) , decreasing the risk 2007; Garland et al., 2006; Grant, 2002) and autoimmune diseases (Hypponen, Laara, Reunanen, Jarvelin, & Virtanen, 2001; Munger, Levin, Hollis, Howard, & Ascherio, 2006 (Holick, 2012) . Many patients with SLOS demonstrate skin photosensitivity and tend to avoid direct exposure to sunlight by wearing protective clothing and sunscreen. In fact, following the first detailed description of photosensitivity in 1998 (Charman et al., 1998) , the photosensitivity to ultraviolet A radiation has been observed in many more patient cohorts (Anstey, 2001) including the patients being followed at NIH as part of our natural history study (unpublished observation).
The active form of vitamin D, 1,25(OH) 2 D, maintains blood calcium in the normal range by enhancing the efficiency of intestinal and renal calcium absorption (Holick, 1996) . However, the best indicator of vitamin D status is serum 25[OH]D, as it is the major circulating form of vitamin D and reflects both the amount produced in the skin following sun exposure and the amount obtained from foods (Holick, 2007) The NIHCC pediatric cohort included 867 patients for whom complete data sets (excluding 7-DHC levels) were available.
| Laboratory values
All biochemical analysis was done at the Mayo Medical Laboratories 
| RESULTS
Demographic data are presented in Table 1 . A total of 53 SLOS and 867 NIHCC pediatric patients were included in the study between 1998 and 2006. The total number of blood draws was 267 and 2287 for these two groups, respectively. There was an equal distribution of males and females (p = 0.64), but the SLOS subjects were, on average, younger than the control group (p < 0.01). Consistent with a northern European predominance of DHCR7 mutations (Porter, 2008) , there was a higher proportion of white subjects (p < 0.01) in the SLOS cohort.
The mean serum 25(OH)D concentration for the SLOS pediatric cohort (48.06 ± 19.53 ng/ml) was significantly increased (p < 0.01) compared to the mean concentration of 25(OH)D (30.51 ± 16.14 ng/ml) for the NIHCC pediatric patient population (Table 2 ). In addition, there was a marked seasonal effect for 25(OH) D levels in both the SLOS and NIHCC patient populations. As one would anticipate since sun exposure influences serum 25(OH)D level, we observed the highest mean concentrations during the summer and fall seasons for both groups (Table 2) season of year and latitude (Reusch, Ackermann, & Badenhoop, 2009 ).
Factors such as sunscreen use, ethnicity and age affect vitamin D status as well (Holick, 2007) . Despite limited sunlight exposure and photosensitivity reported in many patients with SLOS (Anstey, 2001; Charman et al., 1998; Eapen, 2007) Although no SLOS participants were actively supplemented with vitamin D, some subjects received a normal multivitamin or were on a formula that contained vitamin D. This is likely also true for the control group. Abnormally elevated 7-DHC levels may however, 
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